Cargando…
PLLA Coating of Active Implants for Dual Drug Release
Cochlear implants, like other active implants, rely on precise and effective electrical stimulation of the target tissue but become encapsulated by different amounts of fibrous tissue. The current study aimed at the development of a dual drug release from a PLLA coating and from the bulk material to...
Autores principales: | Wulf, Katharina, Goblet, Madeleine, Raggl, Stefan, Teske, Michael, Eickner, Thomas, Lenarz, Thomas, Grabow, Niels, Paasche, Gerrit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875406/ https://www.ncbi.nlm.nih.gov/pubmed/35209205 http://dx.doi.org/10.3390/molecules27041417 |
Ejemplares similares
-
Dual Drug Delivery in Cochlear Implants: In Vivo Study of Dexamethasone Combined with Diclofenac or Immunophilin Inhibitor MM284 in Guinea Pigs
por: Behrends, Wiebke, et al.
Publicado: (2023) -
Effect of Immunophilin Inhibitors on Cochlear Fibroblasts and Spiral Ganglion Cells
por: Goblet, Madeleine, et al.
Publicado: (2023) -
Optical absorbance of the tympanic membrane in rat and human samples
por: Goblet, Madeleine, et al.
Publicado: (2021) -
A PLLA Coating Does Not Affect the Insertion Pressure or Frictional Behavior of a CI Electrode Array at Higher Insertion Speeds
por: Dohr, Dana, et al.
Publicado: (2022) -
Novel dalbavancin-PLLA implant coating prevents hematogenous Staphylococcus aureus infection in a minimally invasive mouse tail vein model
por: Kloss, Marlen, et al.
Publicado: (2022)